)
Visual
test
West Pharmaceutical Services
West Pharmaceutical Services (WST) investor relations material
West Pharmaceutical Services 2026 KeyBanc Capital Markets Healthcare Forum summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.2026 KeyBanc Capital Markets Healthcare Forum summary18 Mar, 2026
Business model and market position
Holds a 70%-75% market share with a strong competitive moat, especially in biologics, ensuring long-term durability and customer retention.
Rarely loses molecules once specified into a product, benefiting from secular tailwinds and robust execution.
2025 performance and transition
2025 marked a significant transition, with momentum building in both GLP-1 and core businesses, exceeding expectations.
Successfully managed destocking in High-Value Components and transitioned SmartDose to AbbVie, improving business economics.
Demand outpaced supply in non-GLP-1 business by year-end, setting up strong momentum for 2026.
2026 outlook and guidance
Forecasts 5%-7% top-line growth for 2026, with most growth from non-GLP-1 business, especially High-Value Products (HVP).
GLP-1 growth is conservatively guided at 10%, down from 50% in 2025, with upside potential.
Non-GLP-1 business expected to grow high single to low double digits, supported by strong demand and capacity expansion.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from West Pharmaceutical Services
- Growth driven by biologics, GLP-1s, and HVPs, with margin expansion and leadership transition.WST
Barclays 28th Annual Global Healthcare Conference25 Mar 2026 - Director elections, say-on-pay, auditor ratification, and Board Chair policy up for vote.WSTProxy Filing12 Mar 2026
- Strong 2025 results, independent board, and robust pay-for-performance governance.WSTProxy Filing12 Mar 2026
- Record 2025 sales, 8% EPS growth, and strong 2026 outlook driven by HVP and biologics.WSTQ4 202512 Feb 2026
- Integrated syringe system accelerates development, simplifies compliance, and ensures supply reliability.WSTStatus update5 Feb 2026
- Q2 sales and profit declined, but organic growth and recovery are expected in Q4.WSTQ2 20242 Feb 2026
- High-value products and biologics drive growth, supported by automation and global expansion.WSTThe 44th Annual William Blair Growth Stock Conference31 Jan 2026
- Keytruda and Gardasil fuel global growth as pipeline and market diversification accelerate.WSTBank of America Global Healthcare Conference 202420 Jan 2026
- Q3 2024 sales steady, profit down; guidance and dividend both increased.WSTQ3 202418 Jan 2026
Next West Pharmaceutical Services earnings date
Q1 202623 Apr, 2026
West Pharmaceutical Services
Next West Pharmaceutical Services earnings date
Q1 202623 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage